Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Breast Cancer Res Treat. 2017 Feb 8;162(3):511–521. doi: 10.1007/s10549-017-4132-9

Table 3.

Associations between baseline miRNA expression and clinico-pathologic parameters

miR-7 miR-200c miR-340 miR-125b miR-155
[p]
ductal type ↓ <0.01 ↓ 0.04
Grade 3 ↓ 0.03 ↓ 0.01
Estrogen receptor positivity ↓ 0.04 ↓ 0.03
Progesterone receptor positivity ↓ <0.01
HER2 positivity ↓ 0.03 ↓ <0.01
Estrogen receptor-positive/HER2 negative status ↓ <0.01 ↓ 0.02 ↓ 0.02

p, two-sided level of significance assessed by Mann-Whitney test

↑, higher expression associated with the respective clinico-pathologic parameter

↓, lower expression associated with the respective clinico-pathologic parameter

miRNAs not demonstrating significant associations with any clinico-pathologic parameter (miR-21, -29a, -29b, -451, -34a) are not shown